{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:04:28Z","timestamp":1791345868304,"version":"4.3.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["22K07831 and 25K11116 [HS]"],"award-info":[{"award-number":["22K07831 and 25K11116 [HS]"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03795-2","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:07:57Z","timestamp":1776150477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum and CSF cytokine profile impact clinical phenotype in pediatric MOGAD"],"prefix":"10.1186","volume":"23","author":[{"given":"Eri","family":"Ohashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniko","family":"Kohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahoko","family":"Miyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomasa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8736-9027","authenticated-orcid":false,"given":"Hiroshi","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"5","key":"3795_CR1","doi-asserted-by":"publisher","first-page":"e200275","DOI":"10.1212\/NXI.0000000000200275","volume":"11","author":"CE Moseley","year":"2024","unstructured":"Moseley CE, Virupakshaiah A, Forsthuber TG, Steinman L, Waubant E, Zamvil SS. MOG CNS Autoimmunity and MOGAD. Neurol Neuroimmunol Neuroinflamm. 2024;11(5):e200275.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"3795_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382.","journal-title":"Lancet Neurol"},{"key":"3795_CR3","doi-asserted-by":"publisher","first-page":"103689","DOI":"10.1016\/j.msard.2022.103689","volume":"59","author":"TL Fabri","year":"2022","unstructured":"Fabri TL, O\u2019Mahony J, Fadda G, Gur RE, Gur RC, Yeh EA, et al. Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2022;59:103689.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"3795_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/jnnp-2024-333994","volume":"96","author":"S Passoke","year":"2025","unstructured":"Passoke S, Stern C, H\u00e4u\u00dfler V, K\u00fcmpfel T, Havla J, Engels D, et al. Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study). J Neurol Neurosurg Psychiatry. 2025;96(3):296\u2013305.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"3795_CR5","doi-asserted-by":"publisher","first-page":"e200309","DOI":"10.1212\/NXI.0000000000200309","volume":"11","author":"Y Xu","year":"2024","unstructured":"Xu Y, Meng H, Fan M, Yin L, Sun J, Yao Y, et al. A Simple Score (MOG-AR) to Identify Individuals at High Risk of Relapse After MOGAD Attack. Neurol Neuroimmunol Neuroinflamm. 2024;11(6):e200309.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"3795_CR6","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1093\/brain\/awad122","volume":"146","author":"Y Matsumoto","year":"2023","unstructured":"Matsumoto Y, Kaneko K, Takahashi T, Takai Y, Namatame C, Kuroda H, et al. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids. Brain. 2023;146(9):3938\u201348.","journal-title":"Brain"},{"issue":"1","key":"3795_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/WNL.0000000000012175","volume":"97","author":"T Akaishi","year":"2021","unstructured":"Akaishi T, Takahashi T, Misu T, Kaneko K, Takai Y, Nishiyama S, et al. Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder. Neurology. 2021;97(1):e1\u201312.","journal-title":"Neurology"},{"issue":"9","key":"3795_CR8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/jnnp-2018-317969","volume":"89","author":"K Kaneko","year":"2018","unstructured":"Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, et al. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. J Neurol Neurosurg Psychiatry. 2018;89(9):927\u201336.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"3795_CR9","doi-asserted-by":"publisher","first-page":"e0149411","DOI":"10.1371\/journal.pone.0149411","volume":"11","author":"K Kothur","year":"2016","unstructured":"Kothur K, Wienholt L, Tantsis EM, Earl J, Bandodkar S, Prelog K, et al. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine\/Chemokines Are Elevated in MOG Antibody Associated Demyelination. PLoS ONE. 2016;11(2):e0149411.","journal-title":"PLoS ONE"},{"key":"3795_CR10","doi-asserted-by":"publisher","first-page":"1014071","DOI":"10.3389\/fnins.2023.1014071","volume":"17","author":"K Kohyama","year":"2023","unstructured":"Kohyama K, Nishida H, Kaneko K, Misu T, Nakashima I, Sakuma H. Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein. Front Neurosci. 2023;17:1014071.","journal-title":"Front Neurosci"},{"key":"3795_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2020.00119","volume":"11","author":"F Tea","year":"2020","unstructured":"Tea F, Pilli D, Ramanathan S, Lopez JA, Merheb V, Lee FXZ, et al. Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry. Front Immunol. 2020;11:119.","journal-title":"Front Immunol"},{"key":"3795_CR12","doi-asserted-by":"publisher","first-page":"1037812","DOI":"10.3389\/fimmu.2022.1037812","volume":"13","author":"A Bauer","year":"2022","unstructured":"Bauer A, Rudzki D, Berek K, Dinoto A, Lechner C, Wendel EM, et al. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Front Immunol. 2022;13:1037812.","journal-title":"Front Immunol"},{"issue":"2","key":"3795_CR13","doi-asserted-by":"publisher","first-page":"e200362","DOI":"10.1212\/NXI.0000000000200362","volume":"12","author":"J Villacieros-\u00c1lvarez","year":"2025","unstructured":"Villacieros-\u00c1lvarez J, Espejo C, Arrambide G, Dinoto A, Mulero P, Rubio-Flores L, et al. Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurol Neuroimmunol Neuroinflamm. 2025;12(2):e200362.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3795_CR14","doi-asserted-by":"crossref","unstructured":"Yandamuri SS, Filipek B, Obaid AH, Lele N, Thurman JM, Makhani N, et al. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity. JCI Insight. 2023;8(11):e165373.","DOI":"10.1172\/jci.insight.165373"},{"issue":"22","key":"3795_CR15","doi-asserted-by":"publisher","first-page":"e2504","DOI":"10.1212\/WNL.0000000000201260","volume":"99","author":"P Barreras","year":"2022","unstructured":"Barreras P, Vasileiou ES, Filippatou AG, Fitzgerald KC, Levy M, Pardo CA, et al. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease. Neurology. 2022;99(22):e2504\u201316.","journal-title":"Neurology"},{"issue":"2","key":"3795_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.25648","volume":"87","author":"P Durozard","year":"2020","unstructured":"Durozard P, Rico A, Boutiere C, Maarouf A, Lacroix R, Cointe S, et al. Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases. Ann Neurol. 2020;87(2):256\u201366.","journal-title":"Ann Neurol"},{"key":"3795_CR17","doi-asserted-by":"publisher","first-page":"102251","DOI":"10.1016\/j.msard.2020.102251","volume":"44","author":"DH Whittam","year":"2020","unstructured":"Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, Gornall M, Cicconi S, et al. Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients. Mult Scler Relat Disord. 2020;44:102251.","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"3795_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.25291","volume":"84","author":"M Spadaro","year":"2018","unstructured":"Spadaro M, Winklmeier S, Beltr\u00e1n E, Macrini C, H\u00f6ftberger R, Schuh E, et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann Neurol. 2018;84(2):315\u201328.","journal-title":"Ann Neurol"},{"issue":"6","key":"3795_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17\u2009+\u2009T helper cells. Cell. 2006;126(6):1121\u201333.","journal-title":"Cell"},{"issue":"6","key":"3795_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.immuni.2015.11.010","volume":"43","author":"NB Pikor","year":"2015","unstructured":"Pikor NB, Astarita JL, Summers-Deluca L, Galicia G, Qu J, Ward LA, et al. Integration of Th17- and Lymphotoxin-Derived Signals Initiates Meningeal-Resident Stromal Cell Remodeling to Propagate Neuroinflammation. Immunity. 2015;43(6):1160\u201373.","journal-title":"Immunity"},{"issue":"1","key":"3795_CR21","doi-asserted-by":"publisher","first-page":"102429","DOI":"10.1016\/j.autrev.2019.102429","volume":"19","author":"JMG Ruiz de Morales","year":"2020","unstructured":"Ruiz de Morales JMG, Puig L, Daud\u00e9n E, Ca\u00f1ete JD, Pablos JL, Mart\u00edn AO, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmun Rev. 2020;19(1):102429.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3795_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol. 2009;9(6):393\u2013407.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3795_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nm1715","volume":"14","author":"IM Stromnes","year":"2008","unstructured":"Stromnes IM, Cerretti LM, Liggitt D, Harris RA, Goverman JM. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med. 2008;14(3):337\u201342.","journal-title":"Nat Med"},{"issue":"1","key":"3795_CR24","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/s41467-020-16625-7","volume":"11","author":"AM Agasing","year":"2020","unstructured":"Agasing AM, Wu Q, Khatri B, Borisow N, Ruprecht K, Brandt AU, et al. Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica. Nat Commun. 2020;11(1):2856.","journal-title":"Nat Commun"},{"issue":"5","key":"3795_CR25","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448\u201357.","journal-title":"Nat Immunol"},{"issue":"9","key":"3795_CR26","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1073\/pnas.1017385108","volume":"108","author":"N Chihara","year":"2011","unstructured":"Chihara N, Aranami T, Sato W, Miyazaki Y, Miyake S, Okamoto T, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A. 2011;108(9):3701\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3795_CR27","doi-asserted-by":"crossref","unstructured":"Ringelstein M, Ayzenberg I, Lindenblatt G, Fischer K, Gahlen A, Novi G, et al. Interleukin-6 receptor blockade in treatment-refractory MOG-IgG-Associated disease and neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2022;9(1):e1100.","DOI":"10.1212\/NXI.0000000000001100"},{"key":"3795_CR28","unstructured":"H-L. R. A study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in patients with myelin oligodendrocyte glycoprotein antibody\u2013associated disease (Meteoroid). 2023. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05271409. Accessed 16 Oct 2023."},{"key":"3795_CR29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1742-2094-9-93","volume":"9","author":"MC Kowarik","year":"2012","unstructured":"Kowarik MC, Cepok S, Sellner J, Grummel V, Weber MS, Korn T, et al. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J Neuroinflammation. 2012;9:93.","journal-title":"J Neuroinflammation"},{"key":"3795_CR30","doi-asserted-by":"crossref","unstructured":"Harrer C, Otto F, Radlberger RF, Moser T, Pilz G, Wipfler P, et al. The CXCL13\/CXCR5 immune axis in health and disease-implications for Intrathecal B cell activities in neuroinflammation. Cells. 2022;11(17):2649.","DOI":"10.3390\/cells11172649"},{"issue":"1","key":"3795_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12974-023-02695-z","volume":"20","author":"V Schropp","year":"2023","unstructured":"Schropp V, Chunder R, Dietel B, Tacke S, Kuerten S. The presence of cerebellar B cell aggregates is associated with a specific chemokine profile in the cerebrospinal fluid in a mouse model of multiple sclerosis. J Neuroinflammation. 2023;20(1):18.","journal-title":"J Neuroinflammation"},{"issue":"Pt 4","key":"3795_CR32","first-page":"1089","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130(Pt 4):1089\u2013104.","journal-title":"Brain"},{"issue":"7","key":"3795_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nri3700","volume":"14","author":"C Pitzalis","year":"2014","unstructured":"Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol. 2014;14(7):447\u201362.","journal-title":"Nat Rev Immunol"},{"key":"3795_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.msard.2018.09.025","volume":"26","author":"C Wicken","year":"2018","unstructured":"Wicken C, Nguyen J, Karna R, Bhargava P. Leptomeningeal inflammation in multiple sclerosis: Insights from animal and human studies. Mult Scler Relat Disord. 2018;26:173\u201382.","journal-title":"Mult Scler Relat Disord"},{"issue":"Pt 10","key":"3795_CR35","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1093\/brain\/aws189","volume":"135","author":"SR Choi","year":"2012","unstructured":"Choi SR, Howell OW, Carassiti D, Magliozzi R, Gveric D, Muraro PA, et al. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain. 2012;135(Pt 10):2925\u201337.","journal-title":"Brain"},{"key":"3795_CR36","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3389\/fimmu.2018.01707","volume":"9","author":"AT Hutloff","year":"2018","unstructured":"Hutloff AT. Follicular Helper-Like Cells in Inflamed Non-Lymphoid Tissues. Front Immunol. 2018;9:1707.","journal-title":"Front Immunol"},{"issue":"5","key":"3795_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00401-020-02132-y","volume":"139","author":"R H\u00f6ftberger","year":"2020","unstructured":"H\u00f6ftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, et al. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. 2020;139(5):875\u201392.","journal-title":"Acta Neuropathol"},{"key":"3795_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2015.00470","volume":"6","author":"AK Dang","year":"2015","unstructured":"Dang AK, Tesfagiorgis Y, Jain RW, Craig HC, Kerfoot SM. Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune Disease. Front Immunol. 2015;6:470.","journal-title":"Front Immunol"},{"issue":"5","key":"3795_CR39","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","volume":"143","author":"Y Takai","year":"2020","unstructured":"Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143(5):1431\u201346.","journal-title":"Brain"},{"key":"3795_CR40","doi-asserted-by":"crossref","unstructured":"Brioschi S, Wang WL, Peng V, Wang M, Shchukina I, Greenberg ZJ, et al. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS borders. Science. 2021;373(6553):eabf9277.","DOI":"10.1126\/science.abf9277"},{"issue":"9","key":"3795_CR41","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41593-021-00880-y","volume":"24","author":"D Schafflick","year":"2021","unstructured":"Schafflick D, Wolbert J, Heming M, Thomas C, Hartlehnert M, B\u00f6rsch AL, et al. Single-cell profiling of CNS border compartment leukocytes reveals that B cells and their progenitors reside in non-diseased meninges. Nat Neurosci. 2021;24(9):1225\u201334.","journal-title":"Nat Neurosci"},{"issue":"17","key":"3795_CR42","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1016\/j.cell.2023.07.009","volume":"186","author":"ZI Kolabas","year":"2023","unstructured":"Kolabas ZI, Kuemmerle LB, Perneczky R, F\u00f6rstera B, Ulukaya S, Ali M, et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell. 2023;186(17):3706\u2013e2529.","journal-title":"Cell"},{"key":"3795_CR43","doi-asserted-by":"crossref","unstructured":"Kwon YN, Kim B, Kim JS, Mo H, Choi K, Oh SI, et al. Myelin oligodendrocyte glycoprotein-immunoglobulin G in the CSF: clinical implication of testing and association with disability. Neurol Neuroimmunol Neuroinflamm. 2022;9(1):e1095.","DOI":"10.1212\/NXI.0000000000001095"},{"issue":"12","key":"3795_CR44","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1136\/jnnp-2024-333554","volume":"95","author":"G Greco","year":"2024","unstructured":"Greco G, Risi M, Masciocchi S, Businaro P, Rigoni E, Zardini E, et al. Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis. J Neurol Neurosurg Psychiatry. 2024;95(12):1176\u201386.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"3795_CR45","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/jamaneurol.2017.4601","volume":"75","author":"Y Hacohen","year":"2018","unstructured":"Hacohen Y, Wong YY, Lechner C, Jurynczyk M, Wright S, Konuskan B, et al. Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. JAMA Neurol. 2018;75(4):478\u201387.","journal-title":"JAMA Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03795-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03795-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:52:54Z","timestamp":1779677574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03795-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3795"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03795-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional and\/or national research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the Ethics Committee and Institutional Review Board of the Tokyo Metropolitan Institute of Medical Science (approval number #15\u2009\u2212\u20093, 18\u2009\u2212\u20093, 21\u2009\u2212\u20092). Informed consent was obtained from the guardians of all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Hiroshi Sakuma received an honorarium from Chugai Pharmaceutical Co. Ltd. The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}